Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
32
ZGN Quote, Financials, Valuation and Earnings
Last price:
$7.94
Seasonality move
:
19.02%
Day range:
$7.94 - $8.10
52-week range:
$7.13 - $15.26
Dividend yield:
0%
P/E ratio:
20.55x
P/S ratio:
0.97x
P/B ratio:
2.21x
Volume:
615.7K
Avg. volume:
807.2K
1-year change:
-26.81%
Market cap:
$2B
Revenue:
$2.1B
EPS (TTM):
$0.42
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.2B | $1.5B | $1.6B | $2.1B | |
| Revenue Growth (YoY) | 5.93% | -21.66% | 31.95% | 2.96% | 30.97% | |
| Cost of Revenues | $762.9M | $613.8M | $586.5M | $595.7M | $736.4M | |
| Gross Profit | $716.3M | $545M | $942.6M | $978.7M | $1.3B | |
| Gross Profit Margin | 48.42% | 47.03% | 61.65% | 62.16% | 64.28% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $373.3M | $325M | $1.1B | $822.8M | $1.1B | |
| Other Inc / (Exp) | -$18M | -$30.8M | -$1.4M | -$18.5M | -$14.5M | |
| Operating Expenses | $595.3M | $532.4M | $1.1B | $822.8M | $1.1B | |
| Operating Income | $121M | $12.6M | -$111.3M | $155.8M | $225.3M | |
| Net Interest Expenses | $25.5M | $17.9M | $2.1M | $30.7M | $27.8M | |
| EBT. Incl. Unusual Items | $77.5M | -$36M | -$114.7M | $106.6M | $183.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $49M | $17.1M | $36.3M | $37.8M | $36.2M | |
| Net Income to Company | $28.5M | -$53.1M | -$151M | $68.8M | $146.9M | |
| Minority Interest in Earnings | -$4.1M | -$4.6M | -$9.9M | -$14.6M | -$15.3M | |
| Net Income to Common Excl Extra Items | $24.3M | -$57.8M | -$160.9M | $54.3M | $131.6M | |
| Basic EPS (Cont. Ops) | $0.10 | -$0.24 | -$0.79 | $0.23 | $0.53 | |
| Diluted EPS (Cont. Ops) | $0.10 | -$0.24 | -$0.79 | $0.22 | $0.52 | |
| Weighted Average Basic Share | $242.3M | $242.3M | $203.5M | $237.5M | $247M | |
| Weighted Average Diluted Share | $242.3M | $242.3M | $204.9M | $240.6M | $252.4M | |
| EBITDA | $296.7M | $172.5M | $84.2M | $304.8M | $425.4M | |
| EBIT | $98.5M | -$17.3M | -$98.3M | $123.5M | $216.3M | |
| Revenue (Reported) | $1.5B | $1.2B | $1.5B | $1.6B | $2.1B | |
| Operating Income (Reported) | $121M | $12.6M | -$111.3M | $155.8M | $225.3M | |
| Operating Income (Adjusted) | $98.5M | -$17.3M | -$98.3M | $123.5M | $216.3M | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $1.5B | $1.6B | $1.8B | $2.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $737.3M | $523M | $643.5M | $731.9M | |
| Gross Profit | -- | $719.9M | $1B | $1.1B | $1.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $365.7M | $1.2B | $927.3M | $1.2B | |
| Other Inc / (Exp) | -$7.9M | -$31.1M | -$22.3M | -$1M | -$12.4M | |
| Operating Expenses | -- | $572.1M | $1.1B | $927.3M | $1.2B | |
| Operating Income | -- | $147.8M | -$83.7M | $195M | $177.4M | |
| Net Interest Expenses | $19.3M | -- | $27.5M | $54.4M | $14.9M | |
| EBT. Incl. Unusual Items | -- | $138M | -$133.5M | $139.6M | $150.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $50M | $27M | $37.5M | $26.4M | |
| Net Income to Company | -- | $88M | -$160.5M | $102.1M | $123.7M | |
| Minority Interest in Earnings | $1.2M | -$11M | -$12.3M | -$13.7M | -$15.3M | |
| Net Income to Common Excl Extra Items | -- | $77M | -$172.8M | $88.4M | $108.4M | |
| Basic EPS (Cont. Ops) | -- | $0.32 | -$0.71 | $0.37 | $0.43 | |
| Diluted EPS (Cont. Ops) | -- | $0.32 | -$0.71 | $0.36 | $0.42 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | $359.2M | $50M | $378.9M | $403.2M | |
| EBIT | -- | $167.5M | -$130.4M | $198.5M | $166.6M | |
| Revenue (Reported) | -- | $1.5B | $1.6B | $1.8B | $2.1B | |
| Operating Income (Reported) | -- | $147.8M | -$83.7M | $195M | $177.4M | |
| Operating Income (Adjusted) | -- | $167.5M | -$130.4M | $198.5M | $166.6M | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | 2025-01-08 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $235.9M | $390.3M | $520.6M | $272.7M | $327.5M | |
| Short Term Investments | $430.6M | $430.7M | $385.4M | $341.7M | $100.3M | |
| Accounts Receivable, Net | $199.6M | $170.8M | $181.6M | $190M | $265.8M | |
| Inventory | $352.4M | $395.4M | $383.2M | $440.6M | $577.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $103.3M | $82.1M | $77.9M | $90.7M | $105.3M | |
| Total Current Assets | $1.4B | $1.5B | $1.6B | $1.4B | $1.4B | |
| Property Plant And Equipment | $823.3M | $732.8M | $545.7M | $538M | $766.7M | |
| Long-Term Investments | $71M | $64.3M | $61.3M | $57.3M | $57M | |
| Goodwill | $253.2M | $256.9M | $257.3M | $257.1M | $283.3M | |
| Other Intangibles | $217.2M | $220.1M | $224.2M | $231.9M | $349.3M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $3B | $3B | $2.8B | $2.6B | $3.1B | |
| Accounts Payable | $213.3M | $184.8M | $201.3M | $236.8M | $288.6M | |
| Accrued Expenses | $36.3M | $24.3M | $17.3M | $24.8M | $31.5M | |
| Current Portion Of Long-Term Debt | $118.8M | $130.4M | $178.1M | $306.9M | $319.8M | |
| Current Portion Of Capital Lease Obligations | $114.8M | $114.2M | $120.7M | $119.5M | $135.6M | |
| Other Current Liabilities | $16M | $36.8M | $72.9M | $60.2M | $58M | |
| Total Current Liabilities | $680.4M | $658.6M | $795.2M | $929.8M | $1.1B | |
| Long-Term Debt | $580.9M | $692.5M | $534M | $198.3M | $125.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.1B | $2.2B | $2.1B | $1.8B | $2.1B | |
| Common Stock | $4.8M | $5.3M | $6.7M | $6.4M | $10.1M | |
| Other Common Equity Adj | -$291.3M | -$363.8M | -$276.8M | -$140.6M | -$139.3M | |
| Common Equity | $771.5M | $740.1M | $680.7M | $728.1M | $928.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $45.9M | $53.2M | $48.8M | $57.2M | $67M | |
| Total Equity | $817.4M | $793.4M | $729.5M | $785.3M | $995.9M | |
| Total Liabilities and Equity | $3B | $3B | $2.8B | $2.6B | $3.1B | |
| Cash and Short Terms | $666.6M | $820.9M | $906M | $614.5M | $427.8M | |
| Total Debt | $699.6M | $822.9M | $712.1M | $505.2M | $445.1M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $340.3M | $362.4M | $277.2M | $241.5M | |
| Short Term Investments | -- | $396.2M | $339M | $117.1M | $106.3M | |
| Accounts Receivable, Net | -- | $173.1M | $176.2M | $236M | $232.2M | |
| Inventory | -- | $398.8M | $408.4M | $592.5M | $579.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $88.9M | $84.9M | $108.3M | $113.6M | |
| Total Current Assets | -- | $1.8B | $1.4B | $1.4B | $1.3B | |
| Property Plant And Equipment | -- | $512.2M | $510.5M | $735.9M | $790.3M | |
| Long-Term Investments | -- | $74.4M | $61.1M | $54.7M | $59.2M | |
| Goodwill | -- | -- | -- | $256.2M | $289.8M | |
| Other Intangibles | -- | -- | -- | $334.9M | $347.9M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $2.9B | $2.6B | $2.9B | $3B | |
| Accounts Payable | -- | $227.1M | $238.8M | $322.7M | $302.1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $216.9M | $257.5M | $307.6M | $180M | |
| Current Portion Of Capital Lease Obligations | -- | $74.6M | $108.9M | $132.3M | $143.2M | |
| Other Current Liabilities | -- | $196.7M | $204.4M | $280.1M | $249.9M | |
| Total Current Liabilities | -- | $756.1M | $873M | $1.1B | $934.2M | |
| Long-Term Debt | -- | $639.7M | $319.8M | $122.5M | $233.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $2.1B | $1.9B | $2B | $2B | |
| Common Stock | -- | $5.1M | $6.2M | $6.6M | $9.8M | |
| Other Common Equity Adj | -- | -$321.8M | $141.6M | $231M | $240.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $52.7M | $49.1M | $57.6M | $66M | |
| Total Equity | -- | $837.4M | $709.7M | $885.6M | $979.9M | |
| Total Liabilities and Equity | -- | $2.9B | $2.6B | $2.9B | $3B | |
| Cash and Short Terms | -- | $736.5M | $701.3M | $394.2M | $347.8M | |
| Total Debt | -- | $856.6M | $577.3M | $430.2M | $413.9M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $28.5M | -$53.1M | -$151M | $68.8M | $146.9M | |
| Depreciation & Amoritzation | $198.2M | $189.8M | $182.4M | $181.3M | $209.1M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$9.4M | $40.7M | -$14.5M | -$16.5M | -$55.2M | |
| Change in Inventories | -$6M | -$45.1M | -$32.6M | -$108.7M | -$78.8M | |
| Cash From Operations | $194.9M | $81M | $332.7M | $154.4M | $298.1M | |
| Capital Expenditures | $66.6M | $44.7M | $111.6M | $77.3M | $84.3M | |
| Cash Acquisitions | -$10.5M | -$2.6M | -$5.4M | -$616.9K | -$144.4M | |
| Cash From Investing | $94M | $105.7M | -$97M | -$60.5M | $23.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$120.7K | -$23M | -$27.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $146.5M | $303M | $146.2M | -- | $221.3M | |
| Long-Term Debt Repaid | -$429.1M | -$356M | -$313.7M | -$300.8M | -$467.6M | |
| Repurchase of Common Stock | -$105.2K | -$1.1M | -$538.8M | -- | -- | |
| Other Financing Activities | -$16.7M | -$2M | -$136.7M | -$4.4M | -$6.6M | |
| Cash From Financing | -$299.5M | -$56M | -$75.8M | -$313.2M | -$271.2M | |
| Beginning Cash (CF) | $244.4M | $240.5M | $375.4M | $484.9M | $275.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$10.5M | $130.7M | $159.8M | -$219.3M | $50.5M | |
| Ending Cash (CF) | $235.8M | $362.4M | $544M | $268.2M | $320.8M | |
| Levered Free Cash Flow | $128.3M | $36.3M | $221.1M | $77.1M | $213.8M | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $88M | -$160.5M | $102.1M | $123.7M | |
| Depreciation & Amoritzation | -- | $186.7M | $180.4M | $180.4M | $236.6M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -$24.9M | -$9.6M | -$41.8M | -$3.1M | |
| Change in Inventories | -- | -$33.7M | -$45.4M | -$139.1M | -$16M | |
| Cash From Operations | -- | $270.8M | $247.9M | $238M | $310.4M | |
| Capital Expenditures | $19.2M | $55.5M | $110.2M | $83.4M | $111.4M | |
| Cash Acquisitions | -$1.9M | -$4.3M | -$1.7M | -$131.2M | -$30.4M | |
| Cash From Investing | -- | -$71M | -$7.3M | $22.8M | -$130.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $70.5M | $68.7M | $70.9M | $316.7M | |
| Long-Term Debt Repaid | -- | -$141.4M | -$386.1M | -$396.7M | -$474.4M | |
| Repurchase of Common Stock | -- | -$1.6M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$89.3M | -$17.8M | -$26.9M | |
| Cash From Financing | -- | -$108.7M | -$185.3M | -$346.1M | -$211.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $83.6M | $69.6M | -$91.4M | -$33.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | $215.4M | $137.7M | $154.6M | $199M | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | 2025-01-08 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get ZGN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ZGN
Sector
P/E ratio
20.55x
16.64x
PEG ratio
--
0.22x
P/B ratio
2.21x
1.47x
Price / LTM sales
0.97x
0.71x
Growth Metrics
ZGN
Sector
Revenue growth
--
0.45%
Earnings growth
--
--
Revenue (5-year growth)
8.11%
3.45%
Earnings forecast
--
$0.30
Profitability
ZGN
Sector
Profitability FY 2023
$1.3B
$492.8M
Return on invested capital
7.83%
5.14%
Return on assets
3.64%
3.05%
Return on equity
11.36%
7.55%
Earnings Date
Last Earnings Date
Oct
22
Next Earnings Date
Jan
31
Estimated Next Earnings Date
Jan
21
Balance Sheet
ZGN
Sector
Total cash
$347.8M
$153.4M
Short term investments
$100.3M
$59.8M
Total assets
$3.1B
$1.6B
Long term debt
$413.9M
$111.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
